Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
- 21 August 2003
- journal article
- website
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 26 (9) , 1887-1896
Abstract
Risk stratification and effectiveness of implantable cardioverter‐defibrillator (ICD) therapy are unresolved issues in hypertrophic cardiomyopathy (HCM), a cardiac disease that is associated with arrhythmias and sudden death. We assessed ICD therapy in 132 patients with HCM: age at implantation was 34 ± 17 years , and 44 (33%) patients were aged ≤ 20 years . Indications were sustained ventricular tachycardia (VT) or cardiac arrest (secondary prevention) in 47 (36%) patients, and clinical features associated with increased risk for sudden death (primary prevention) in 85 (64%) patients. There were 6 deaths and 55 appropriate interventions in 27 (20%) patients during a mean follow‐up period of 4.8 ± 4.2 years : 5‐year survival and event‐free rates were 96%± 2% and 75%± 5% , respectively. ICD intervention‐free rates were significantly less for secondary than for primary prevention: 64%± 7% versus 84%± 6% at 5 years, P = 0.02 . Notably, 59 of 67 events (cardiac arrest and therapeutic ICD interventions), or 88%, occurred during sedentary or noncompetitive activity. Incidence of therapeutic shocks was related to age but not to other reported risk factors, including severity of cardiac hypertrophy, nonsustained VT during Holter monitoring, and abnormal blood pressure response to exercise. ICD related complications occurred in 38 (29%) patients, including 60 inappropriate ICD interventions in 30 (23%) patients. However, 8 (27%) of the patients with inappropriate shocks also had therapeutic interventions. ICD is effective for secondary prevention of sudden death in HCM. However, selection of patients for primary prevention of sudden death, and prevention of device related complications require further refinement. (PACE 2003; 26:1887–1896)Keywords
This publication has 45 references indexed in Scilit:
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- Hypertrophic Cardiomyopathy: valuation and Treatment of Patients at High Risk for Sudden DeathPacing and Clinical Electrophysiology, 1997
- Five-year experience with implantable defibrillators in childrenThe American Journal of Cardiology, 1996
- Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrestThe American Journal of Cardiology, 1991
- Prognosis in hypertrophic cardiomyopathyAmerican Heart Journal, 1984
- Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective studyThe American Journal of Cardiology, 1981
- Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic featuresThe American Journal of Cardiology, 1981
- Sudden death in young athletes.Circulation, 1980
- Idiopathic hypertrophic subaortic stenosis in the youngThe American Journal of Cardiology, 1978
- “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature deathThe American Journal of Cardiology, 1978